Lipid Lowering
Lipid lowering therapy in primary prevention in women has been proven to lower cardiovascular events. (quality of evidence I, Grade A recommendation) [1][10]
Women at high risk for IHD (diabetics, vascular disease elsewhere) should be treated with pharmacotherapy as per guidelines (consensus, quality of evidence II, Grade A recommendation). [1][10]
The 2003 update of the Canadian recommendations for the management of dyslipidemia and the prevention of cardiovascular disease is available throught the CMAJ [12] and in greater depth at this link.
_________________________________
1. Amberson, B.L., (2000) Risk Factors and Primary Prevention of Ischemic Heart Disease in Women. Canadian Cardiovascular Society Consensus Conference: Women and Ischemic Heart Disease, October 2000: 4/1-4/25.
10. Mosca L, et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women. AHA/ACC 2004 Scientific Statement. Circulation 2004;109:672-693.
12. Genest J, Frohlich J, Fodor G and McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003; 169 (9):921 http://www.cmaj.ca/cgi/content/full/169/9/921 accessed March 27, 2006
